NSE adds six securities to ESM Stage I effective April 30, 2026, requiring 100% margin and shift from Rolling Settlement to Trade-for-Trade segment from May 4, 2026.
Impact
High
Severity
High
Justification
Six securities face immediate trading restrictions including 100% margin requirements and mandatory shift to Trade-for-Trade segment, significantly impacting liquidity and trading flexibility for holders of these stocks.
NSE adds 14 securities to ST-ASM Stage I effective April 22, 2026, imposing 50% margin requirement on all open and new positions from April 23, 2026. No securities added to Stage II.
Impact
High
Severity
High
Justification
14 stocks placed under ST-ASM Stage I with mandatory 50% margin requirement effective immediately, directly impacting trading costs and position limits for market participants holding or trading these securities.
List of securities subject to Reversal Trade Cancellation Mechanism (RTCM) for December 2025, covering over 300 stocks where specific trade cancellation procedures will apply.
Impact
Medium
Severity
Medium
Justification
Affects trading operations for over 300 securities with specific trade cancellation procedures. Important for traders and market participants dealing with these stocks to understand RTCM applicability.
NSE circular announcing securities subject to Short-Term Additional Surveillance Measure (ST-ASM) framework effective October 31, 2025, including one new addition and two exclusions.
Impact
Medium
Severity
Medium
Justification
Affects trading conditions for 29 securities under ASM framework with one new addition (UTSSAV) to Stage I and two exclusions (BANCOINDIA, V2RETAIL). Medium impact as it applies enhanced surveillance measures to specific securities.
NSE circular detailing securities added to and excluded from the Short-Term Additional Surveillance Measure (ST-ASM) framework effective October 29, 2025.
Impact
Medium
Severity
Medium
Justification
Affects trading conditions for specific securities under surveillance framework. Limited to 3 new entries in Stage-I and 4 exclusions, impacting liquidity and trading costs for these stocks.